Cargando…

Manipulation of Gut Microbiota Influences Immune Responses, Axon Preservation, and Motor Disability in a Model of Progressive Multiple Sclerosis

Gut microbiota dysbiosis has been implicated in MS and other immune diseases, although it remains unclear how manipulating the gut microbiota may affect the disease course. Using a well-established model of progressive MS triggered by intracranial infection with Theiler's murine encephalomyelit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mestre, Leyre, Carrillo-Salinas, Francisco Javier, Mecha, Miriam, Feliú, Ana, Espejo, Carmen, Álvarez-Cermeño, José Carlos, Villar, Luisa María, Guaza, Carmen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587398/ https://www.ncbi.nlm.nih.gov/pubmed/31258540 http://dx.doi.org/10.3389/fimmu.2019.01374

Ejemplares similares

Aging and neuroinflammation: Changes in immune cell responses, axon integrity, and motor function in a viral model of progressive multiple sclerosis
por: Mestre, Leyre, et al.
Publicado: (2021)

Perspectives on Cannabis-Based Therapy of Multiple Sclerosis: A Mini-Review
por: Mecha, Miriam, et al.
Publicado: (2020)

Viral models of multiple sclerosis: Neurodegeneration and demyelination in mice infected with Theiler's virus
por: Mecha, Miriam, et al.
Publicado: (2013)

How oral probiotics affect the severity of an experimental model of progressive multiple sclerosis? Bringing commensal bacteria into the neurodegenerative process
por: Mestre, Leyre, et al.
Publicado: (2020)

Regulatory Lymphocytes Are Key Factors in MHC-Independent Resistance to EAE
por: Marín, Nieves, et al.
Publicado: (2014)

Brain Innate Immunity in the Regulation of Neuroinflammation: Therapeutic Strategies by Modulating CD200-CD200R Interaction Involve the Cannabinoid System
por: Hernangómez, Miriam, et al.
Publicado: (2014)

Involvement of Wnt7a in the role of M2c microglia in neural stem cell oligodendrogenesis
por: Mecha, Miriam, et al.
Publicado: (2020)

Gut dysbiosis and neuroimmune responses to brain infection with Theiler’s murine encephalomyelitis virus
por: Carrillo-Salinas, F. J., et al.
Publicado: (2017)

Hypoxia mimetic activity of VCE-004.8, a cannabidiol quinone derivative: implications for multiple sclerosis therapy
por: Navarrete, Carmen, et al.
Publicado: (2018)

The Dual PDE7-GSK3β Inhibitor, VP3.15, as Neuroprotective Disease-Modifying Treatment in a Model of Primary Progressive Multiple Sclerosis
por: Benítez-Fernández, Rocio, et al.
Publicado: (2022)

A Cannabigerol Derivative Suppresses Immune Responses and Protects Mice from Experimental Autoimmune Encephalomyelitis
por: Carrillo-Salinas, Francisco J., et al.
Publicado: (2014)

Therapeutic potential of extracellular vesicles derived from human mesenchymal stem cells in a model of progressive multiple sclerosis
por: Laso-García, Fernando, et al.
Publicado: (2018)

Anandamide inhibits Theiler's virus induced VCAM-1 in brain endothelial cells and reduces leukocyte transmigration in a model of blood brain barrier by activation of CB(1 )receptors
por: Mestre, Leyre, et al.
Publicado: (2011)

Cannabidiol protects oligodendrocyte progenitor cells from inflammation-induced apoptosis by attenuating endoplasmic reticulum stress
por: Mecha, M, et al.
Publicado: (2012)

Expression of Concern: Manipulation of Gut Microbiota Influences Immune Responses, Axon Preservation, and Motor Disability in a Model of Progressive Multiple Sclerosis
Publicado: (2020)

A Commercial Probiotic Induces Tolerogenic and Reduces Pathogenic Responses in Experimental Autoimmune Encephalomyelitis
por: Calvo-Barreiro, Laura, et al.
Publicado: (2020)

Selected Clostridia Strains from The Human Microbiota and their Metabolite, Butyrate, Improve Experimental Autoimmune Encephalomyelitis
por: Calvo-Barreiro, Laura, et al.
Publicado: (2021)

Axonal loss in major sensorimotor tracts is associated with impaired motor performance in minimally disabled multiple sclerosis patients
por: Strik, Myrte, et al.
Publicado: (2021)

Identification of the Immunological Changes Appearing in the CSF During the Early Immunosenescence Process Occurring in Multiple Sclerosis
por: Picón, Carmen, et al.
Publicado: (2021)

Acetate correlates with disability and immune response in multiple sclerosis
por: Pérez-Pérez, Silvia, et al.
Publicado: (2020)

Cannabinoid Receptors Modulate Neuronal Morphology and AnkyrinG Density at the Axon Initial Segment
por: Tapia, Mónica, et al.
Publicado: (2017)

Axonal degeneration in multiple sclerosis: can we predict and prevent permanent disability?
por: Lee, Jae Young, et al.
Publicado: (2014)

Relationship of acute axonal damage, Wallerian degeneration, and clinical disability in multiple sclerosis
por: Singh, Shailender, et al.
Publicado: (2017)

Axonal Dysfunction Precedes Motor Neuronal Death in Amyotrophic Lateral Sclerosis
por: Iwai, Yuta, et al.
Publicado: (2016)

Efficacy of Vafidemstat in Experimental Autoimmune Encephalomyelitis Highlights the KDM1A/RCOR1/HDAC Epigenetic Axis in Multiple Sclerosis
por: Cavalcanti, Fernando, et al.
Publicado: (2022)

Axonal Regeneration and Neuronal Function Are Preserved in Motor Neurons Lacking ß-Actin In Vivo
por: Cheever, Thomas R., et al.
Publicado: (2011)

Omics Approach to Axonal Dysfunction of Motor Neurons in Amyotrophic Lateral Sclerosis (ALS)
por: Suzuki, Naoki, et al.
Publicado: (2020)

Acute retigabine‐induced effects on myelinated motor axons in amyotrophic lateral sclerosis
por: Sleutjes, Boudewijn T. H. M., et al.
Publicado: (2022)

DRB1*03:01 Haplotypes: Differential Contribution to Multiple Sclerosis Risk and Specific Association with the Presence of Intrathecal IgM Bands
por: de la Concha, Emilio G., et al.
Publicado: (2012)

CAR-Associated Vesicular Transport of an Adenovirus in Motor Neuron Axons
por: Salinas, Sara, et al.
Publicado: (2009)

CD8(+) T Cells Cause Disability and Axon Loss in a Mouse Model of Multiple Sclerosis
por: Deb, Chandra, et al.
Publicado: (2010)

Abnormal Dynamic Pupillometry Relates to Neurologic Disability and Retinal Axonal Loss in Patients With Multiple Sclerosis
por: Bitirgen, Gulfidan, et al.
Publicado: (2021)

gMS-Classifier1 does not predict disability progression in multiple sclerosis
por: van Rossum, Johannis A, et al.
Publicado: (2018)

Dpr10 and Nocte are required for Drosophila motor axon pathfinding
por: Lobb-Rabe, Meike, et al.
Publicado: (2022)

Manipulation of Axonal Outgrowth via Exogenous Low Forces
por: De Vincentiis, Sara, et al.
Publicado: (2020)

Elevated axonal membrane permeability and its correlation with motor deficits in an animal model of multiple sclerosis
por: Leung, Gary, et al.
Publicado: (2017)

Molecular signature associated with cladribine treatment in patients with multiple sclerosis
por: Fissolo, Nicolas, et al.
Publicado: (2023)

Neurofilament accumulations in amyotrophic lateral sclerosis patients’ motor neurons impair axonal initial segment integrity
por: Lefebvre-Omar, Cynthia, et al.
Publicado: (2023)

Manipulating Microtubules in Systemic Sclerosis
Publicado: (2005)

CD200R1 agonist attenuates glial activation, inflammatory reactions, and hypersensitivity immediately after its intrathecal application in a rat neuropathic pain model
por: Hernangómez, Miriam, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_vvphtce1m82d24c0rra0k4rc3o